Crossmark Global Holdings, Inc. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,077 filers reported holding NOVARTIS A G in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
Crossmark Global Holdings, Inc. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$2,701
-17.1%
27,424
-12.3%
0.06%
-12.9%
Q2 2023$3,260
+17.8%
31,285
+4.0%
0.07%
+7.7%
Q1 2023$2,767
+3.0%
30,078
+1.6%
0.06%
-3.0%
Q4 2022$2,686
-99.9%
29,612
-0.4%
0.07%
+6.3%
Q3 2022$2,260,000
+4.9%
29,723
+16.6%
0.06%
+12.5%
Q2 2022$2,155,000
-8.1%
25,490
-4.6%
0.06%
+7.7%
Q1 2022$2,346,000
+7.1%
26,730
+6.7%
0.05%
+8.3%
Q4 2021$2,190,000
+7.1%
25,040
+0.1%
0.05%0.0%
Q3 2021$2,045,000
-58.4%
25,010
-53.5%
0.05%
-58.3%
Q2 2021$4,911,000
-13.8%
53,830
-19.3%
0.12%
-18.4%
Q1 2021$5,700,000
-24.0%
66,680
-16.0%
0.14%
-25.8%
Q4 2020$7,496,000
+9.4%
79,386
+0.8%
0.19%
-1.0%
Q3 2020$6,851,000
+24.1%
78,782
+24.6%
0.19%
+19.3%
Q2 2020$5,522,000
-28.9%
63,222
-32.9%
0.16%
-42.1%
Q1 2020$7,765,000
-17.4%
94,175
-5.2%
0.28%
+7.8%
Q4 2019$9,405,000
+42.2%
99,321
+30.4%
0.26%
+33.7%
Q3 2019$6,616,000
-30.4%
76,139
-26.9%
0.19%
-27.7%
Q2 2019$9,505,000
-13.1%
104,094
-8.5%
0.27%
-14.1%
Q1 2019$10,941,000
+14.5%
113,799
+2.2%
0.31%
+5.1%
Q4 2018$9,552,000
-1.0%
111,319
-0.5%
0.30%
+20.8%
Q3 2018$9,644,000
+45.6%
111,929
+27.7%
0.24%
+37.6%
Q2 2018$6,624,000
-43.2%
87,683
-39.3%
0.18%
-41.1%
Q1 2018$11,672,000
+5.6%
144,372
+9.7%
0.30%
+14.0%
Q4 2017$11,049,000
-12.0%
131,594
-10.0%
0.26%
-18.2%
Q3 2017$12,559,0000.0%146,2900.0%0.32%0.0%
Q3 2016$12,559,000146,2900.32%
Other shareholders
NOVARTIS A G shareholders Q3 2022
NameSharesValueWeighting ↓
Martin Investment Management, LLC 229,184$23,344,6827.00%
Foresight Global Investors, Inc. 97,500$9,397,7375.23%
SCHARF INVESTMENTS, LLC 1,425,745$145,226,3224.34%
MANAGED ASSET PORTFOLIOS, LLC 274,204$27,930,3694.28%
GARLAND CAPITAL MANAGEMENT INC 54,710$5,572,7613.93%
PRENTISS SMITH & CO INC 52,032$5,299,9803.91%
WILKINS INVESTMENT COUNSEL INC 130,950$13,3393.61%
First Fiduciary Investment Counsel, Inc. 145,731$14,8443.48%
Cullen Capital Management, LLC 2,714,809$276,530,4643.23%
JOHN G ULLMAN & ASSOCIATES INC 182,690$18,608,8033.04%
View complete list of NOVARTIS A G shareholders